SS Innovations Competitors
| SSII Stock | 4.83 -0.07 -1.43% |
SS Innovations vs Progyny Correlation Details
Weak diversification
Across the chosen horizon, SS Innovations and Progyny show a correlation of 0.51 and fall into the Weak diversification bucket. Lower overlap tends to improve diversification, while higher overlap means both positions carry similar risk.
Moving together with SSII Stock
Moving against SSII Stock
The mean reversion principle applied to SS Innovations' suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of SS Innovations' price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in SS Innovations' price is a well-documented phenomenon in academic research. In many cases, SS Innovations' price extremes present statistical patterns that have recurred historically.
SS Innovations Competition Correlation Matrix
Reviewing how SS Innovations International moves relative to competing stocks can show whether peer exposure is reducing portfolio risk or simply repeating the same market bet. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Strong recent returns in SSII Stock do not always mean SS Innovations Company is outperforming peers on business quality. Without risk-adjusted context, investors may overweight short-term returns and underweight the volatility required to achieve them. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| UFPT | 1.95 | -0.14 | 0.00 | -0.17 | 0.00 | 3.61 | 16.42 | |||
| CNMD | 1.76 | -0.07 | 0.00 | -0.45 | 0.00 | 3.36 | 11.74 | |||
| ESTA | 2.44 | -0.28 | 0.00 | -0.35 | 0.00 | 4.55 | 13.50 | |||
| PRCT | 3.08 | -0.27 | 0.00 | -0.23 | 0.00 | 6.86 | 22.79 | |||
| SDGR | 2.59 | -0.46 | 0.00 | -0.34 | 0.00 | 4.96 | 21.90 | |||
| OMCL | 2.16 | -0.28 | 0.00 | -0.24 | 0.00 | 3.97 | 22.92 | |||
| OMDA | 2.88 | 0.01 | 0.00 | -0.06 | 0.00 | 5.05 | 18.17 | |||
| AHCO | 2.17 | 0.21 | 0.07 | 0.37 | 3.12 | 5.30 | 18.48 | |||
| TDOC | 2.59 | -0.26 | 0.00 | -0.19 | 0.00 | 5.09 | 18.44 | |||
| PGNY | 2.10 | -0.45 | 0.00 | -0.68 | 0.00 | 3.62 | 25.79 |
Peer Comparison: Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in SS Innovations financial statement analysis. It represents the amount of money remaining after all of SS Innovations International operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Compare SS Innovations and related stocks such as UFP Technologies, CONMED, and Establishment Labs Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UFPT | 200 K | 10.3 M | 10.9 M | 11.3 M | 7.6 M | 7.6 M | 8 M | 9.2 M | 14.3 M | 19.8 M | 13.4 M | 15.9 M | 41.8 M | 44.9 M | 59 M | 68.3 M | 71.7 M |
| CNMD | 700 K | 752 K | 40.5 M | 35.9 M | 32.2 M | 30.5 M | 14.7 M | 55.5 M | 40.9 M | 28.6 M | 9.5 M | 62.5 M | -80.6 M | 64.5 M | 132.4 M | 47.1 M | 24.4 M |
| ESTA | -1.6 M | -1.6 M | -1.6 M | -1.6 M | -1.6 M | -1.6 M | -22.2 M | -34.9 M | -21.1 M | -38.1 M | -38.1 M | -41.1 M | -75.2 M | -78.5 M | -84.6 M | -51.1 M | -53.6 M |
| PRCT | -42 M | -42 M | -42 M | -42 M | -42 M | -42 M | -42 M | -42 M | -42 M | -42 M | -53 M | -59.9 M | -87.2 M | -105.9 M | -91.4 M | -95.6 M | -100.4 M |
| SDGR | -17.4 M | -17.4 M | -17.4 M | -17.4 M | -17.4 M | -17.4 M | -17.4 M | -17.4 M | -28.4 M | -24.6 M | -24.5 M | -100.4 M | -149.2 M | 40.7 M | -187.1 M | -103.3 M | -108.4 M |
| OMCL | -20.8 M | 10.4 M | 16.2 M | 24 M | 30.5 M | 30.8 M | 603 K | 20.6 M | 37.7 M | 61.3 M | 32.2 M | 77.8 M | 5.6 M | -20.4 M | 12.5 M | 2.1 M | 1.9 M |
| OMDA | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -72.5 M | -67.5 M | -47.1 M | -12.8 M | -13.4 M |
| AHCO | -3.8 M | -3.8 M | -3.8 M | -3.8 M | -3.8 M | -3.8 M | -3.8 M | -690 | 2.1 M | -21.3 M | -161.6 M | 156.2 M | 69.3 M | -678.9 M | 90.4 M | -70.8 M | -74.3 M |
| TDOC | -6 M | -6 M | -6 M | -6 M | -17 M | -58 M | -74.2 M | -106.8 M | -97.1 M | -98.9 M | -485.1 M | -428.8 M | -13.7 B | -220.4 M | -1 B | -200.3 M | -210.3 M |
| PGNY | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | 661 K | -8.6 M | 46.5 M | 65.8 M | 30.4 M | 62 M | 54.3 M | 58.5 M | 36.3 M |
SS Innovations Competitive Analysis
How does SS Innovations measure up against UFP Technologies, CONMED, and Establishment Labs? The financials tell a nuanced story. SS Innovations operates at a 1.07 B scale with 42.4 M flowing through the income statement. SS Innovations currently operates at a -32.11% net margin with return on equity at -43.42%, reflecting headwinds in the current cycle. UFP Technologies leads on revenue, 602.8 M to 42.4 M, a substantial gap. On the bottom line, CONMED retains 3.42% while SS Innovations manages -32.11%. On equity returns, SS Innovations earns -43.42% compared to -133.25% at Establishment Labs.| Better Than Average | Worse Than Peers | View Performance Chart |
SS Innovations Competition Peer Performance Charts
How to Analyze SS Innovations Against Peers
SS Innovations' peer analysis compares SS Innovations with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:- Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
- Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
- Check valuation dispersion: Review whether SS Innovations trades at a premium or discount versus peers and why.
- Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
- Document the thesis: Record where SS Innovations leads or lags and what catalysts could close or widen the gap.
Peer Comparison Metrics & Methodology
Operating expenses at SS Innovations as a share of revenue sit below the peer group midpoint, signaling tighter cost control. Relative analysis can highlight whether current pricing already reflects peer-group strengths or weaknesses. For peer comparison, SS Innovations has a market cap of 1.07 B, profit margin of -32.11%.
Reported values for SS Innovations International are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability.